# Efficacy Study of a Novel Skin Health Product to Reduce an UVB Induced Erythema

> **NCT05300542** · NA · COMPLETED · sponsor: **Amazentis SA** · enrollment: 22 (actual)

## Conditions studied

- Erythema
- Sun Damaged Skin
- Skin Inflammation

## Interventions

- **OTHER:** Topical Placebo Cream
- **OTHER:** Topical Cream with 0.5% Active
- **OTHER:** Topical Cream with 1% Active

## Key facts

- **NCT ID:** NCT05300542
- **Lead sponsor:** Amazentis SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-17
- **Primary completion:** 2022-03-31
- **Final completion:** 2022-04-13
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2023-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05300542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05300542, "Efficacy Study of a Novel Skin Health Product to Reduce an UVB Induced Erythema". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05300542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*